Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | NR1H3 | Q13133 | 8/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 6/20 | 0.44 |
| ▸ | RORC | P51449 | 3/20 | 0.44 |
| ▸ | RORA | P35398 | 2/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | AR | P10275 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL832913 | 0.89 | NR1H3 (0.47) | NR1H3MEN1ALOX15TSHRMAPK1 | |
| SCHEMBL26548517 | 0.86 | NR1H3 (0.44) | NR1H3MEN1ALOX15TSHRMAPK1 | |
| SCHEMBL24436844 | 0.86 | NR1H3 (0.44) | NR1H3MEN1ALOX15TSHRMAPK1 | |
| SCHEMBL10165246 | 0.86 | NR1H3 (0.44) | NR1H3MEN1ALOX15TSHRMAPK1 | |
| SCHEMBL17914398 | 0.83 | ACHE (0.50) | ACHEHDAC4HDAC2HDAC8ALOX15 | |
| SCHEMBL29509593 | 0.83 | TSHR (0.50) | NR1H3MEN1ALOX15TSHRMAPK1 | |
| SCHEMBL24901407 | 0.83 | TSHR (0.50) | NR1H3MEN1ALOX15TSHRMAPK1 | |
| SCHEMBL22928005 | 0.83 | ACHE (0.53) | ACHEHDAC4HDAC2HDAC8MEN1 | |
| SCHEMBL9095009 | 0.83 | ACHE (0.53) | ACHEHDAC4HDAC2HDAC8MEN1 | |
| SCHEMBL23059982 | 0.82 | GABRA1 (0.50) | NR1H3MEN1ALOX15TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230039535-A1 | COMPOSITION, COMPOSITION PRECURSOR SOLUTION, PRODUCTION METHOD FOR COMPOSITION, SUBSTRATE WITH MULTILAYER FILM, AND PRODUCTION METHOD FOR PATTERNED SUBSTRATE | CENTRAL GLASS COMPANY, LIMITED (JP) | 2023-02-09 | — | — | US | disclosed |
| US-20210082690-A1 | Silicon-Containing Layer-Forming Composition, and Method for Producing Pattern-Equipped Substrate Which Uses Same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2021-03-18 | — | — | US | disclosed |
| US-20210061827-A1 | Silicon Compound Containing Hexafluoroisopropanol Group, and Method for Producing Same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2021-03-04 | — | — | US | disclosed |
| US-9874816-B2 | Radiation-sensitive resin composition and resist pattern-forming method | JSR CORPORATION (JP) | 2018-01-23 | — | — | US | disclosed |
| US-20170363961-A9 | RADIATION-SENSITIVE RESIN COMPOSITION AND RESIST PATTERN-FORMING METHOD | JSR CORPORATION (JP) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210061827-A1 | Silicon Compound Containing Hexafluoroisopropanol Group, and Method for Producing Same | FOS, FUBP3, SF3A3 | ACHE 3458/4885HDAC4 2105/4885HDAC2 429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.